Revenue: The sum of all revenue fields included for a company's operating activities.
Iterum Therapeutics PLC (ITRM) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-6.51M |
|
$0.34M |
|
$-0.34M |
|
$5.53M |
|
$-5.53M |
|
$-0.92M |
|
$-6.45M |
|
$-6.45M |
|
$-6.51M |
|
$-6.51M |
|
$-6.51M |
|
$-6.51M |
|
$-5.53M |
|
$-5.18M |
|
39.94M |
|
39.94M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$14.89M |
|
$0.01M |
|
$19.12M |
|
$34.01M |
|
$5.53M |
|
$20.65M |
|
$32.37M |
|
$37.90M |
|
$-3.89M |
|
$-22.95M |
|
$-3.89M |
|
42.13M |
|
| Cash Flow Statement Financials | |
$-7.81M |
|
$-0.00M |
|
$-3.27M |
|
$24.16M |
|
$13.06M |
|
$-11.10M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.69 |
|
-- |
|
-- |
|
1.23 |
|
-5.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
-- |
|
-- |
|
167.46% |
|
28.37% |
|
-19.14% |
|
-38.82% |
|
$-0.09 |
|
$-0.20 |
|
$-0.20 |
|